New Market Report: Brazil Pharmaceuticals & Healthcare Report Q1 2016
Brazil's pharmaceutical market will become increasingly unattractive to pharmaceutical companies due to the growing fiscal tightening in the country. Multinational drugmakers will face the risk of revenue decreases, due to increasing generic competition and more intensified cost-containment measurement s.
View full press release